Watcharapol Mahaprom undergoes a blood test at the Ozone Foundation. A Thai man has been talking about how he is able to reduce the harm caused by using the drug crystal meth thanks to a programme ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...

Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.

The Ghana AIDS Commission (GAC) says the lack of funding can  impact negatively efforts to end AIDS as a public health threat ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Expanded treatment options, increased naloxone distribution and targeted education campaigns likely led to a 37% reduction in ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...